Ibalizumab biosimilar(Oneness Biotech)

N/A

Report date: 2025/03/07 17:34:28

Base Information

Drug NameIbalizumab biosimilar(Oneness Biotech)
Drug Alias NameFB-121
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Biosimilar
Mechanisms of ActionVirus internalization inhibitorsT-cell surface antigen CD4 inhibitorsHIV fusion inhibitors
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFountain Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesFountain Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A